Media Summary: Erin Wysong Hofstatter, MD, associate professor, co-director, Cancer Genetics and Prevention Program, Yale Cancer Center, ... Mattias Johansson, International Agency for Research on Cancer, Lyon, France, emphasizes the importance of Laura Mezquita, MD, PhD, Hospital Clinic - IDIBAPS, Barcelona, Spain, comments on findings from a prospective study of 350 ...

Identifying High Risk Individuals - Detailed Analysis & Overview

Erin Wysong Hofstatter, MD, associate professor, co-director, Cancer Genetics and Prevention Program, Yale Cancer Center, ... Mattias Johansson, International Agency for Research on Cancer, Lyon, France, emphasizes the importance of Laura Mezquita, MD, PhD, Hospital Clinic - IDIBAPS, Barcelona, Spain, comments on findings from a prospective study of 350 ... Jeffrey Lancet, MD, of H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, discusses the Jill Corre, PharmD, PhD, The Cancer University Institute of Toulouse Oncopole (IUCT), Toulouse, France, discusses the ... A regional roundtable discussion, moderated by Shilpa Gupta, MD, Cleveland Clinic, examined current and emerging strategies ...

Mayo Clinic researchers are looking for better ways to It's crucial for every healthcare organization to analyze its There are things that you can do to start improving and reducing the psychosocial Farrukh Awan, MD, UT Southwestern Medical Center, Dallas, TX, discusses the cardiac side effects associated with treatment with ... Wee Joo Chng, MB ChB, MRCP, MRCPath, PhD, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, ... In this video, Shankara Anand, MS, Broad Institute of MIT & Harvard, Cambridge, MA, discusses genomic profiling of smoldering ...

NASH** and **T2DM** impose massive clinical and economic burdens. To improve diagnosis, **qFibrosis** uses **AI** and ... Anne Kushwaha, MD, Director of the Memorial Hermann Southwest Breast Center, Houston Breast Imaging provided information ... Eileen Boyle, MD, PhD, NYU Langone, New York City, NY, outlines the clinical and genetic factors contributing to poorer ...

Photo Gallery

Identifying high-risk individuals
Dr. Hofstatter on Identifying High-Risk Patients in Breast Cancer
The importance of identifying high-risk lung cancer patients for screening
SARI Clinical Management: Identifying High-Risk Patients (English)
Identifying high-risk patients with NSCLC excluded from screening programs
Identifying high-risk AML
A new classification for identifying high-risk myeloma based on cytogenetic abnormalities
Identifying High-Risk Cancer Patients
Follicular lymphoma: identifying high-risk patients
Identifying High-Risk Patients: Predictors of Progression to CRPC
Identifying High Breast Cancer Risk - Mayo Clinic
B EYE Solutions - Identifying High-Risk Patients
Sponsored
Sponsored
View Detailed Profile
Identifying high-risk individuals

Identifying high-risk individuals

An overview of the criteria used to

Dr. Hofstatter on Identifying High-Risk Patients in Breast Cancer

Dr. Hofstatter on Identifying High-Risk Patients in Breast Cancer

Erin Wysong Hofstatter, MD, associate professor, co-director, Cancer Genetics and Prevention Program, Yale Cancer Center, ...

Sponsored
The importance of identifying high-risk lung cancer patients for screening

The importance of identifying high-risk lung cancer patients for screening

Mattias Johansson, International Agency for Research on Cancer, Lyon, France, emphasizes the importance of

SARI Clinical Management: Identifying High-Risk Patients (English)

SARI Clinical Management: Identifying High-Risk Patients (English)

SARI Clinical Management:

Identifying high-risk patients with NSCLC excluded from screening programs

Identifying high-risk patients with NSCLC excluded from screening programs

Laura Mezquita, MD, PhD, Hospital Clinic - IDIBAPS, Barcelona, Spain, comments on findings from a prospective study of 350 ...

Sponsored
Identifying high-risk AML

Identifying high-risk AML

Jeffrey Lancet, MD, of H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, discusses the

A new classification for identifying high-risk myeloma based on cytogenetic abnormalities

A new classification for identifying high-risk myeloma based on cytogenetic abnormalities

Jill Corre, PharmD, PhD, The Cancer University Institute of Toulouse Oncopole (IUCT), Toulouse, France, discusses the ...

Identifying High-Risk Cancer Patients

Identifying High-Risk Cancer Patients

WOWT 6 News 10

Follicular lymphoma: identifying high-risk patients

Follicular lymphoma: identifying high-risk patients

Patients

Identifying High-Risk Patients: Predictors of Progression to CRPC

Identifying High-Risk Patients: Predictors of Progression to CRPC

A regional roundtable discussion, moderated by Shilpa Gupta, MD, Cleveland Clinic, examined current and emerging strategies ...

Identifying High Breast Cancer Risk - Mayo Clinic

Identifying High Breast Cancer Risk - Mayo Clinic

Mayo Clinic researchers are looking for better ways to

B EYE Solutions - Identifying High-Risk Patients

B EYE Solutions - Identifying High-Risk Patients

It's crucial for every healthcare organization to analyze its

High Risk Mental Health: How Do You Identify The High Risk Individuals In Your Organisation?

High Risk Mental Health: How Do You Identify The High Risk Individuals In Your Organisation?

There are things that you can do to start improving and reducing the psychosocial

Identifying patients with CLL at a high risk of developing cardiotoxicity with BTK inhibitors

Identifying patients with CLL at a high risk of developing cardiotoxicity with BTK inhibitors

Farrukh Awan, MD, UT Southwestern Medical Center, Dallas, TX, discusses the cardiac side effects associated with treatment with ...

Identifying high-risk myeloma: looking beyond cytogenetic factors

Identifying high-risk myeloma: looking beyond cytogenetic factors

Wee Joo Chng, MB ChB, MRCP, MRCPath, PhD, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, ...

How Doctors Identify High-Risk Multiple Myeloma (HRMM) Using Genetics

How Doctors Identify High-Risk Multiple Myeloma (HRMM) Using Genetics

HTUmyeloma

Genomic profiling of smoldering myeloma identifies high- and low- risk patients

Genomic profiling of smoldering myeloma identifies high- and low- risk patients

In this video, Shankara Anand, MS, Broad Institute of MIT & Harvard, Cambridge, MA, discusses genomic profiling of smoldering ...

Identify High Risk MASH

Identify High Risk MASH

NASH** and **T2DM** impose massive clinical and economic burdens. To improve diagnosis, **qFibrosis** uses **AI** and ...

Identifying High Risk Breast Cancer Patients - Fourth Thursdays: Lunch & Learn Webinar

Identifying High Risk Breast Cancer Patients - Fourth Thursdays: Lunch & Learn Webinar

Anne Kushwaha, MD, Director of the Memorial Hermann Southwest Breast Center, Houston Breast Imaging provided information ...

Identifying high-risk multiple myeloma patient subgroups using genetic and clinical factors

Identifying high-risk multiple myeloma patient subgroups using genetic and clinical factors

Eileen Boyle, MD, PhD, NYU Langone, New York City, NY, outlines the clinical and genetic factors contributing to poorer ...